Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000304200 | SCV000338459 | uncertain significance | not provided | 2015-12-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000304200 | SCV002007333 | uncertain significance | not provided | 2021-04-08 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV002518966 | SCV003243487 | likely benign | Type A2 brachydactyly; Acromesomelic dysplasia 3 | 2023-12-09 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003920095 | SCV004735257 | uncertain significance | BMPR1B-related disorder | 2023-11-16 | no assertion criteria provided | clinical testing | The BMPR1B c.289A>G variant is predicted to result in the amino acid substitution p.Thr97Ala. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.016% of alleles in individuals of East Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/4-96036878-A-G). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |